论文部分内容阅读
目的分析无创通气联合沙美特罗替卡松气雾剂治疗老年慢性阻塞性肺疾病呼吸衰竭的疗效。方法回顾性选择2014年10月-2015年10月本院收治60例老年慢性阻塞性肺疾病呼吸衰竭患者临床资料,按照治疗方法分组,每组30例,对照组采用无创通气治疗,研究组在对照组基础上加以沙美特罗替卡松气雾剂治疗,比较两组治疗前后动脉血气变化情况与肺功能变化情况。结果治疗后研究组患者血气分析情况及肺功能改善情况均优于对照组,比较差异均具有统计学意义(P<0.05)。结论创通气联合沙美特罗替卡松气雾剂治疗老年慢性阻塞性肺疾病呼吸衰竭的疗效,可通过改善血气情况及肺功能,从而消除临床症状,值得临床推广。
Objective To analyze the curative effect of noninvasive ventilation combined with salmeterol and fluticasone aerosol on respiratory failure in elderly patients with chronic obstructive pulmonary disease. Methods The clinical data of 60 elderly COPD patients with respiratory failure from October 2014 to October 2015 were retrospectively reviewed. Thirty patients in each group were treated by noninvasive ventilation. The patients in control group were treated with noninvasive ventilation The control group was treated with salmeterol and fluticasone aerosol. The changes of arterial blood gas and pulmonary function before and after treatment were compared between the two groups. Results After treatment, the study group blood gas analysis and pulmonary function improvement were better than the control group, the difference was statistically significant (P <0.05). Conclusions The efficacy of Chong ventilation combined with salmeterol and fluticasone aerosol in the treatment of respiratory failure in elderly patients with chronic obstructive pulmonary disease can be clinically promoted by improving blood gas and pulmonary function so as to eliminate clinical symptoms.